West Pharmaceutical Services WST Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's total equity?
- West Pharmaceutical Services (WST) reported total equity of $2.99B in Q1 2026.
- How has West Pharmaceutical Services's total equity changed year-over-year?
- West Pharmaceutical Services's total equity increased by 11.5% year-over-year, from $2.68B to $2.99B.
- What is the long-term trend for West Pharmaceutical Services's total equity?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's total equity has grown at a 11.4% compound annual growth rate (CAGR), from $1.85B to $3.18B.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.